Log in
Enquire now
‌

US Patent 11407747 Compositions and methods for inhibiting kinases

Patent 11407747 was granted and assigned to Inhibikase Therapeutics on August, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Inhibikase Therapeutics
Inhibikase Therapeutics
0
Current Assignee
Inhibikase Therapeutics
Inhibikase Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
114077470
Patent Inventor Names
Milton H. Werner0
Terence A. Kelly0
Date of Patent
August 9, 2022
0
Patent Application Number
171418250
Date Filed
January 5, 2021
0
Patent Citations
‌
US Patent 10118923 Compositions and methods for inhibiting kinases
‌
US Patent 10344027 Compositions and methods for inhibiting kinases
‌
US Patent 10906896 Compositions and methods for inhibiting kinases
‌
US Patent 10316031 Compositions and methods for inhibiting kinases
Patent Primary Examiner
‌
Deepak R Rao
0
CPC Code
‌
C07D 401/14
0
‌
C07D 403/14
0
‌
A61K 31/506
0

The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11407747 Compositions and methods for inhibiting kinases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.